EDITOR'S DESK

  • Give Credit To The U.S. Pharma Industry For Leading Reincorporation
    Give Credit To The U.S. Pharma Industry For Leading Reincorporation

    You’ve got to give credit to companies in our industry. If punitive U.S. taxation policy is going to drive them to do deals overseas, they are going to go big-time and in style. If they are not allowed to repatriate global dollars in a sensible manner, they will invest them with fanfare abroad.

More From The Editor

CLINICAL PERSPECTIVES

  • BRIC Nations: Divergent Patterns in the Clinical Trials Landscape
    BRIC Nations: Divergent Patterns in the Clinical Trials Landscape

    The clinical trial landscape in BRIC countries is changing. Long heralded as a low-cost alternative to Western markets, Brazil, Russia, India and China are experiencing a shift in trial initiation by global sponsors.

  • FDA Safety Labeling Requirements
    FDA Safety Labeling Requirements

    Prior to 2007, the U.S. Food and Drug Administration’s labeling authority was limited; the agency could only request changes to the labeling of approved drug products. That changed, however, with the enactment of the Food and Drug Administration Amendments Act of 2007, in particular, section 505(o)(4). In that section, the FDA was given new authority to require safety labeling changes for approved drugs.

    This means the FDA can now order labeling changes if it becomes aware of new safety information that it believes should be included in the labeling of a drug. This article summarizes the FDA’s thinking in this regard, as indicated by its guidance released in recent weeks.

  • Gaining Greater Predictability, Control And Quality In Bioprocessing With Metabolic Biomarkers
    Gaining Greater Predictability, Control And Quality In Bioprocessing With Metabolic Biomarkers

    Biologics are an integral part of the landscape of current therapies as pipelines continue to fill with them. Due to their importance and this ever expanding pipeline, the demands continue to escalate due to cost pressure, competition, regulatory requirements, disposable systems, and biosimilars. To date, these demands arguably have primarily been met with empirical understanding. However, there is a critical need for new approaches, tools, and technologies to deliver deeper understanding beyond the empirical realm. By Dr. Kirk Beebe, Director of Application Science, Metabolon, Inc.

More Clinical Perspectives

FROM THE INDUSTRY EXPERTS

More From The Industry Experts

WHITE PAPERS AND CASE STUDIES

  • 10 Questions: FDA Compliance Using Electronic Signatures — Part 1
    10 Questions: FDA Compliance Using Electronic Signatures — Part 1

    Digital signatures are a subset of electronic signatures. Digital signatures is the term that we use to describe standard electronic signatures. In the United States, the digital signature standards are published and maintained at the federal government level by the National Institute of Standards and Technology (NIST).

More White Papers & Case Studies

FEATURED SERVICES AND PRODUCTS

  • Neurosciences
    Neurosciences

    Our neuroscience team is driven to help our clients manage the complex world of nervous system disorders to deliver therapies quickly and within budget. While the neuroscience environment is moving at a rapid pace with shortening development times, PPD’s clinical team and medical professionals are prepared to step in and effectively navigate our clients’ trials in disorders of central nervous system (CNS), peripheral nervous system, sleep medicine and pain management.

  • Bio-STAR Technology: Clinical Trial Logistics Management
    Bio-STAR Technology: Clinical Trial Logistics Management

    World Courier pioneered the development of an advanced technology to streamline the management of clinical trial logistics. Unparalleled within the industry, World Courier’s cutting edge technological innovations provide you with logistical tools to effectively manage your study – from the pre-trial phase right through to your last shipment.

  • In-Vitro Diagnostic Device Clinical Trials
    In-Vitro Diagnostic Device Clinical Trials

    LabCorp Clinical Trials provides full-service central laboratory services in support of 510(k) and PMA clinical trials for in vitro diagnostics (IVD). We have extensive experience working with diagnostic companies to bring new tests to market by combining our broad-based laboratory capabilities with expert project management, data management and regulatory insight developed from working over 20 years on thousands of clinical trials across all major therapeutic areas.

  • uPRO™ - Facilitate And Collect Patient-Driven Data
    uPRO™ - Facilitate And Collect Patient-Driven Data

    Collects Patient-Driven Data over the internet. When deployed in conjunction with DATATRAK’s uEDC™ product, study team members access a single location to view and manage all study data.

  • Xcellerate™ Clinical Trial Optimization™
    Xcellerate™ Clinical Trial Optimization™ Research shows that clinical trial enrollment comes up short a good 50% of the time, which costs you valuable time and money. But now there’s a unique new way to better predict which clinical sites are likely to deliver the right patients. So you can engage them from the start and avoid sites that are more likely to underperform.
  • CoSign Cloud
    CoSign Cloud

    From large enterprises to small businesses, CoSign is the proper digital signature solution for anyone looking to finally make the move to more efficient paper-free processes.

  • Biometrics Services
    Biometrics Services

    Chiltern provides fully comprehensive Data Management, EDC Study Build, EDC Training / Consultancy, Statistical and Medical Writing services.

  • eClinical OS Trial Connect Mobile App
    eClinical OS Trial Connect Mobile App

    Access your trials virtually anywhere, at any time. Critical study data – now at your fingertips.

More Featured Services & Products

CRO LEADERSHIP AWARD

                                       
Life Science Leader developed the CRO Leadership Awards based on industry leading research conducted by Nice Insight. This award helps pharma and biopharm companies focus on potential partners who can handle their projects and are considered reputable in the industry. Click on the logo above to visit this year’s winners.

ABOUT CLINICAL LEADER

Welcome to Clinical Leader, the premier online community that helps streamline clinical research by connecting trial sponsors and cutting edge service providers. Clinical Leader is part of the Life Science Connect media group. The vision of Life Science Leader and Life Science Connect is to help facilitate connections and foster collaborations in pharmaceutical and medical device development to find ways to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute.

Visitors are enriched with valuable information on CRO, Pre-Clinical Contract Research Organization, Bio-Analytical Contract Research Organization, Clinical Contract Research Organization, Pharmacovigilance, Clinical Data Management, Electronic Patient Reported Outcomes (ePRO), Point-of-Care Testing (POCT), Patient Recruitment, Electronic Data Capture (EDC), Clinical Trials Management Systems (CTMS) and more that can improve your business and make it more profitable.

Please take a moment to join our community and discover the benefits of your free membership.

Newsletter Signup
Newsletter Signup

PREMIER SERVICE PROVIDER

CLINICAL LEADER WEBINARS

  • Digital Signatures: Enabling Compliant Collaboration and Streamlined Corporate Governance

    In this webinar, we’ll focus on the middle office where life sciences organizations can achieve tangible operational improvements and cost savings.

  • Adaptive Trials In Oncology Research Webinar

    Adaptive trial design is critical in all phases of oncology drug development and helps overcome many hurdles of traditional study design. In a recent webinar, PPD’s Dirk Reitsma, M.D., vice president, global product development, and Niklas Morton, vice president, global biostatistics, programming and medical writing, analyzed the incorporation of adaptive trial design in oncology trials. They were joined by Scott Berry, Ph.D., president and senior statistical scientist with Berry Consultants, to assess the early decision making benefits that are critical to the decreasing drug development time and providing increased benefit to patients.

  • Will BRIC be the Savior for the Life Sciences and Medical Devices Sector?

    Will BRIC be the Savior for the Life Sciences and Medical Devices Sector?  Discover key lessons from the field and best practices vital to reap rewards from these countries during Frost & Sullivan’s complimentary webinar. The briefing will benefit any senior manager in the corporate strategy or global marketing areas that focuses on emerging markets, as well as any healthcare company looking to explore BRIC countries.

  • New Indications For Existing Medical Entities

    This webinar will take a critical view at the diverse technologies that have been proposed for repositioning. 

More From Clinical Leader Webinar

 UPCOMING TRAINING COURSES

Remote Monitoring of Clinical Source Data – Why Not?

July 28, 2014
1pm-2:30pm EDT, Online Training

Serialization Preparedness – What you Must Know for Bullet-Proof Programs

August 12, 2014
1pm-2:30pm EDT, Online Training

Introduction to Biostatistics: Hypothesis Testing

August 14, 2014
1pm-3pm EDT, Online Training

Root Cause Analysis for GCP – A Risk Action Plan Guide

August 19, 2014
1pm-3pm EDT, Online Training
More Upcoming Courses

CLINICAL BULLETIN BOARD

According to the WHO, over 150m people worldwide, are chronically infected with HCV, with 3 to 4m new infections occurring each year. Together they represent a multibillion dollar market for any successful new drug candidate, with Hepatitis C having the most promising products in development.

 CLINICAL EVENTS

Remote Monitoring of Clinical Source Data – Why Not?

July 28, 2014
1pm-2:30pm EDT, Online Training
Price:  $299 - Introductory Rate

Serialization Preparedness – What you Must Know for Bullet-Proof Programs

August 12, 2014
1pm-2:30pm EDT, Online Training
Price:  $299 - Introductory Rate

Introduction to Biostatistics: Hypothesis Testing

August 14, 2014
1pm-3pm EDT, Online Training
Price:  $349 - Introductory Rate
More Events....